UBS Reiterates Buy Rating on Nurix (NRIX)

June 9, 2026 9:30 AM

UBS analyst David Dai reiterated a Buy rating and $23.00 price target on Nurix (NASDAQ: NRIX).The analyst commented, "NRIX announced ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found